Related references
Note: Only part of the references are listed.Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes
Naoko Uno et al.
JOURNAL OF VIROLOGY (2021)
Neuraminidase-associated plasminogen recruitment enables systemic spread of natural avian Influenza viruses H3N1
Jacob Schoen et al.
PLOS PATHOGENS (2021)
Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges
Z. Beau Reneer et al.
JOURNAL OF VIROLOGY (2021)
Neutralizing and Neuraminidase Antibodies Correlate With Protection Against Influenza During a Late Season A/H3N2 Outbreak Among Unvaccinated Military Recruits
Carol D. Weiss et al.
CLINICAL INFECTIOUS DISEASES (2020)
Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic
Hiroko Ito et al.
PLOS ONE (2020)
Vaccination with Consensus H7 Elicits Broadly Reactive and Protective Antibodies against Eurasian and North American Lineage H7 Viruses
Gendeal M. Fadlallah et al.
VACCINES (2020)
Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice
Meagan McMahon et al.
VACCINE (2020)
Progress in the Development of Universal Influenza Vaccines
Wenqiang Sun et al.
VIRUSES-BASEL (2020)
Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus
Haihai Jiang et al.
MBIO (2020)
Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies
Ivan Kosik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains
Ted M. Ross et al.
VACCINE (2019)
Neuraminidase inhibitors as a strategy for influenza treatment: pros, cons and future perspectives
Matteo Bassetti et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Diversity and distribution of type A influenza viruses: an updated panorama analysis based on protein sequences
Qingye Zhuang et al.
VIROLOGY JOURNAL (2019)
Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase
Felix Broecker et al.
JOURNAL OF VIROLOGY (2019)
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice
Iuliia M. Gilchuk et al.
CELL HOST & MICROBE (2019)
Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies
Xueyong Zhu et al.
CELL HOST & MICROBE (2019)
Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance
Yao-Qing Chen et al.
JOURNAL OF VIROLOGY (2019)
Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza
E. R. Job et al.
JOURNAL OF VIROLOGY (2018)
Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments
James A. Williams et al.
JOURNAL OF VIROLOGY (2018)
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
Yao-Qing Chen et al.
CELL (2018)
Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness
Maryna C. Eichelberger et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases
Emily J. Erbelding et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype
Lisa Walz et al.
JOURNAL OF VIROLOGY (2018)
Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses
James D. Allen et al.
PLOS ONE (2018)
Influence of protein fold stability on immunogenicity and its implications for vaccine design
Sandra Scheiblhofer et al.
EXPERT REVIEW OF VACCINES (2017)
Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses
Donald M. Carter et al.
JOURNAL OF VIROLOGY (2017)
Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants
Terianne M. Wong et al.
JOURNAL OF VIROLOGY (2017)
Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms
Ivan Kosik et al.
VIROLOGY (2017)
Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes
Teddy John Wohlbold et al.
NATURE MICROBIOLOGY (2017)
A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release
Seiya Yamayoshi et al.
EBIOMEDICINE (2017)
Data, disease and diplomacy: GISAID's innovative contribution to global health
Stefan Elbe et al.
GLOBAL CHALLENGES (2017)
Late stages of the influenza A virus replication cycle-a tight interplay between virus and host
Marie O. Pohl et al.
JOURNAL OF GENERAL VIROLOGY (2016)
Universal influenza vaccines: Shifting to better vaccines
Francesco Berlanda Scorza et al.
VACCINE (2016)
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
Arnold S. Monto et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses
Kim B. Westgeest et al.
JOURNAL OF VIROLOGICAL METHODS (2015)
Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains
Yo Han Jang et al.
VACCINE (2014)
Stability of neuraminidase in inactivated influenza vaccines
Ishrat Sultana et al.
VACCINE (2014)
Clinical use of approved influenza antivirals: therapy and prophylaxis
Michael G. Ison
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
Robert B. Couch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses
Hongquan Wan et al.
JOURNAL OF VIROLOGY (2013)
Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine
Steven Rockman et al.
JOURNAL OF VIROLOGY (2013)
Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase
Miriam Cohen et al.
VIROLOGY JOURNAL (2013)
Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data
Matthew Kearse et al.
BIOINFORMATICS (2012)
A Computationally Optimized Hemagglutinin Virus-Like Particle Vaccine Elicits Broadly Reactive Antibodies that Protect Nonhuman Primates from H5N1 Infection
Brendan M. Giles et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses
Yoko Shoji et al.
HUMAN VACCINES (2011)
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
James R. R. Whittle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets
Brendan M. Giles et al.
VACCINE (2011)
Effects of Oseltamivir Treatment on Duration of Clinical Illness and Viral Shedding and Household Transmission of Influenza Virus
Sophia Ng et al.
CLINICAL INFECTIOUS DISEASES (2010)
Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase
Jimmy C. C. Lai et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Panorama Phylogenetic Diversity and Distribution of Type A Influenza Virus
Shuo Liu et al.
PLOS ONE (2009)
A preliminary panorama of the diversity of N1 subtype influenza viruses
Ji-Ming Chen et al.
VIRUS GENES (2007)
Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles
Benjamin J. Chen et al.
JOURNAL OF VIROLOGY (2007)
Swine influenza A outbreak, Fort Dix, New Jersey, 1976
JC Gaydos et al.
EMERGING INFECTIOUS DISEASES (2006)
Functional balance between haemagglutinin and neuraminidase in influenza virus infections
R Wagner et al.
REVIEWS IN MEDICAL VIROLOGY (2002)
Influenza A virus neuraminidase: Regions of the protein potentially involved in virus-host interactions
TG Fanning et al.
VIROLOGY (2000)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
